🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

359 results for “vaccine” Clear

  1. Biological/Vaccine: therapeutic autologous dendritic cells.

    LISATA THERAPEUTICS, INC.

    Kidney Cancer

    phase 1 mab terminated

    1 trial

  2. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine

    United Therapeutics Europe Ltd

    HER2 Negative Breast Carcinoma

    phase 1 mab active

    1 trial

  3. CEA protein antigen plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Rectal Cancer

    phase 1 mab active

    1 trial

  4. COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Covid19

    phase 1 mab active

    1 trial

  5. Cam2020 M2SR H3N2 influenza vaccine

    United Therapeutics Europe Ltd

    Influenza Vaccine

    phase 1 mab completed

    1 trial

  6. D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

    United Therapeutics Europe Ltd

    Dengue

    phase 1 mab completed

    1 trial

  7. Dendritic Cell (DC1) Vaccine

    VACCINEX, INC.

    HER2-positive Breast Cancer

    phase 1 mab active

    1 trial

  8. Dendritic Cell Vaccine

    United Therapeutics Europe Ltd

    Leptomeningeal Disease

    phase 1 mab active

    1 trial

  9. Ebola Vaccine - low dose

    United Therapeutics Europe Ltd

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  10. Electroporation-Mediated Plasmid DNA Vaccine Therapy

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis

    phase 1 mab active

    1 trial

  11. Engineered mitochondrial vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor Malignancies

    phase 1 mab active

    1 trial

  12. Experimental Vaccine 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 1 mab completed

    1 trial

  13. FVH1 - a DNA-based influenza vaccine

    INOVIO PHARMACEUTICALS, INC.

    Influenza, Human

    phase 1 mab completed

    1 trial

  14. First-in-human Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of the Adjuvanted Universal Influenza Vaccine “fH1/DSP-0546LP” in Healthy Adults

    Lacuna Pharma Pty Ltd

    Influenza

    phase 1 other active

    1 trial

  15. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  16. HBV mRNA vaccine

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  17. HER-2/neu peptide vaccine

    Marker Therapeutics

    HER2-positive Breast Cancer

    phase 1 mab completed

    1 trial

  18. HER2 Tumor Vaccine

    The First People's Hospital of Lianyungang

    Adenocarcinoma - GEJ

    phase 1 mab active

    1 trial

  19. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  20. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  21. HIV-1 Peptide Vaccine, Microparticulate Monovalent

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  22. ICT-121 DC vaccine

    Chongqing Precision Biotech Co., Ltd

    Glioblastoma Multiforme

    phase 1 mab completed

    1 trial

  23. IL-22BP mRNA vaccine injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Malignant Solid Tumors

    phase 1 mab active

    1 trial

  24. IMP3-saRNA (YMN-136) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 1 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources